Crescent Capital BDC (NASDAQ:CCAP) Price Target Cut to $16.00 by Analysts at Wells Fargo & Company

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) had its price objective cut by equities research analysts at Wells Fargo & Company from $18.00 to $16.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an "equal weight" rating on the stock. Wells Fargo & Company's price objective indicates a potential downside of 1.35% from the stock's current price.

Separately, Keefe, Bruyette & Woods dropped their target price on shares of Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating for the company in a report on Tuesday, April 8th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Crescent Capital BDC currently has an average rating of "Moderate Buy" and a consensus target price of $18.50.

Crescent Capital BDC Stock Up 0.9 %

Shares of NASDAQ CCAP traded up $0.15 during trading on Monday, reaching $16.22. The company had a trading volume of 11,951 shares, compared to its average volume of 142,809. The stock has a market cap of $601.11 million, a PE ratio of 8.15 and a beta of 0.56. The business's 50-day moving average is $16.79 and its 200 day moving average is $18.32. Crescent Capital BDC has a 12-month low of $13.54 and a 12-month high of $20.19. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.56 by ($0.01). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The firm had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. As a group, equities analysts forecast that Crescent Capital BDC will post 2.09 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Montag A & Associates Inc. purchased a new stake in shares of Crescent Capital BDC in the fourth quarter valued at approximately $35,000. C M Bidwell & Associates Ltd. purchased a new position in shares of Crescent Capital BDC during the fourth quarter valued at $39,000. Aquatic Capital Management LLC purchased a new stake in Crescent Capital BDC in the fourth quarter worth about $129,000. Generation Capital Management LLC bought a new position in Crescent Capital BDC during the 4th quarter worth about $192,000. Finally, First Affirmative Financial Network purchased a new position in Crescent Capital BDC during the 1st quarter valued at about $199,000. 49.46% of the stock is currently owned by institutional investors.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.